Patricia Corzine, NP
Nurse Practitioner · Corydon, INNPI 1669466165
Payments from drug & device makers
Across 19 payments — averaging $275.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$5K
- Eisai Inc.$125
- E.r. Squibb & Sons, L.L.C.$119
- Amgen$100
- AVEO Pharmaceuticals, Inc.$90
- Incyte Corporation$68
- plus $112 from 5 others
What the payments were for
- Speaking & faculty fees$4,00077%
- Travel & lodging$2655%
- Food & beverage$75915%
- Education$2024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 8 | $4,611 |
| Eisai Inc. | 1 | $125 |
| E.r. Squibb & Sons, L.L.C. | 1 | $119 |
| Amgen | 1 | $100 |
| AVEO Pharmaceuticals, Inc. | 1 | $90 |
| Incyte Corporation | 1 | $68 |
| Novartis | 2 | $39 |
| AbbVie | 1 | $27 |
| Agios Pharmaceuticals, Inc. | 1 | $20 |
| Seagen Inc. | 1 | $14 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,225 in reported general payments places this provider in the 90th percentile of 2,724 nurse practitioner providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 28 | $30,014 |
| XareltoRivaroxaban | 12 | $9,194 |
| Famotidine | 46 | $520 |
| Anastrozole | 23 | $278 |
| Ondansetron Hcl | 14 | $221 |
| Omeprazole | 26 | $202 |
| Dexamethasone | 13 | $180 |
| Potassium Chloride | 14 | $172 |
| Levothyroxine Sodium | 12 | $155 |
| Gabapentin | 26 | $153 |
| Warfarin Sodium | 17 | $50 |
| Pantoprazole Sodium | 14 | $43 |
| Trazodone Hcl | 12 | $12 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Corydon
- Kristi OrbaughIndianapolis$1.3M
- Kimberly EadsPlainfield$302K
- Sean GoddardFort Wayne$180K
- Kacy RogersIndianapolis$77K
- Kristine TaylorFort Wayne$69K
- Brittany SavageIndianapolis$51K
- Monica HaugerTrafalgar$47K
- Rhonda HettingerClarksville$38K
- Jennifer MaahsIndianapolis$36K
- Amber MillerLawrenceburg$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.